Navigation Links
Steroid Concoction May Ease Sinusitis
Date:3/16/2009

Small study finds benefits, but drug does not have FDA approval for such use

MONDAY, March 16 (HealthDay News) -- A steroid nasal wash can help reduce symptoms of chronic sinusitis without affecting adrenal gland function, according to a small U.S. study.

Chronic sinusitis is a persistent inflammation of the nose and sinuses behind the nose that affects up to 14 percent of people in the United States, according to background information in the study.

The study included nine people who were told to use a nasal wash, composed of 0.25 milligrams of the corticosteroid budesonide and 5 milliliters of saline, in each nostril once a day for 30 days. The budesonide came in respules -- small, plastic, liquid-containing devices.

The researchers, from Washington University School of Medicine in St. Louis, said it was the first study to examine the safety of this type of nasal wash, noting that suppression of adrenal gland function is a known complication of budesonide.

All participants reported at least some improvement in their sinusitis symptoms, and their adrenal gland function was not affected, the study found. The results were published in the March issue of Otolaryngology -- Head & Neck Surgery.

"The clinical significance of this study is that budesonide nasal respules appear safe for short-term use for the relief of symptoms associated with chronic sinusitis," the researchers concluded. "Budesonide respules seem to provide an effective treatment option for the patient with chronic rhinosinusitis with minimal fear of systemic adverse effects."

The U.S. Food and Drug Administration has not approved budesonide as a nasal wash, which means the nasal wash used in this study would be an off-label use of the drug. The researchers urged doctors to warn patients about the risks associated with long-term use of budesonide, including decreased bone mineral density.

More inf
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Steroids ineffective in young children with wheeze
2. 1 in 10 Ex-NFL Players Used Steroids, Poll Reports
3. Inhaled Corticosteroids Boost Pneumonia Risk in COPD
4. High and Super-High Potency Topical Corticosteroids Will Remain Decision Resources Clinical Gold Standard Through 2017 for the Treatment of Atopic Dermatitis
5. Additional Steroid Dose May Help Preemies
6. Twelve Indicted in Nationwide Anabolic Steroids Probe
7. Multiple Doses of Steroids Dont Help Preemies
8. Steroid After Tonsillectomy Raises Bleeding Risk
9. Steroid Inhalers Raise Pneumonia Risk for Lung Disease Patients
10. Study shows steroid therapies following transplant can be eliminated
11. Steroids aid recovery from pneumonia, UT Southwestern researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Steroid Concoction May Ease Sinusitis
Steroid Concoction May Ease Sinusitis
(Date:5/23/2012)... WEDNESDAY, May 23 (HealthDay News) -- The use ... reduced through a multi-pronged approach that includes more ... relatives, according to a new German study. ... ineffective, physical restraints such as bed rails and ... A recent survey found that the rate of ...
(Date:5/23/2012)... Prior treatment with inhaled corticosteroids in patients with ... is associated with a lower incidence and severity ... from researchers in Spain. , A parapneumonic effusion ... that accumulates between the two pleural layers, the ... as a result of a pneumonia, lung abscess, ...
(Date:5/23/2012)... Researchers in the United Kingdom have determined ... anti-inflammatory properties, can be an effective treatment option ... a life-threatening complication that occurs in the majority ... is the leading cause of mortality after the ... when the body repeatedly rejects the transplanted lung ...
(Date:5/22/2012)... Magnetic resonance imaging (MRI) provides an indication ... significantly earlier than possible through clinical examination, according ... journal Radiology . , Women with ... Research has shown that women who receive this ... to achieve breast conservation than those receiving chemotherapy ...
(Date:5/22/2012)... Large randomized controlled trials (RCTs) are critical for ... Yet Canada provides scant support for these studies ... in CMAJ ( Canadian Medical Association ... and Hamilton Health Sciences, Hamilton, Ontario, with Dr. ... the analysis and appendix that Canada should provide ...
Breaking Medicine News(10 mins):Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Canada should significantly increase its funding of randomized clinical trials 2
... company WorldMed Assist says economic downturn has created an uptick in his ... benefit plans that have been dramatically scaled back. , ... Concord, CA ... there were many predictions how this would play out for the young ...
... Dr. Jane L. Delgado, President and CEO ... leading Hispanic health advocacy group, released the following statement ... and Tobacco Control Act, which will provide the Food ... products. "Fifteen years ago Congressman Waxman summoned the ...
... President Obama,s economic stimulus package encourages the use ... this area of healthcare reform to become a reality, ... providers.See video from Siemens (NYSE: SI ) ... Information technology (IT), or the sharing of ...
... fruit, combined with contraceptive pill and a genetic mutation, ... April 2 (HealthDay News) -- A rare set of ... genetic mutation almost cost a 42-year-old woman her leg, ... in the car one afternoon," said Dr. Lucinda Grande, ...
... sports athletesGOLDEN VALLEY, Minn., April 2 ... a history of developing talented, nationally and internationally recognized ... rugby. On Thursday, April 9, at 6 p.m., three ... intent in the Gym at Courage Center Golden Valley. ...
... around us, images flicker into our brains ,like so many ... our eyes move, which is several times a second. Yet ... display. , Why not? , Neuroscientists at The Johns Hopkins ... special region of the brain,s visual cortex ,which is in ...
Other Medicine News:Health News:Economic Turmoil Creates Boom for Medical Tourism 2Health News:Economic Turmoil Creates Boom for Medical Tourism 3Health News:Economic Turmoil Creates Boom for Medical Tourism 4Health News:National Alliance for Hispanic Health Statement on Passage of Bill Granting FDA Authority to Regulate Tobacco 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 3Health News:Courage Center Hosts College Scholarship Signing Ceremony Thursday, April 9, 2009 2Health News:JHU researcher discovers brain cells have 'memory' 2Health News:JHU researcher discovers brain cells have 'memory' 3
(Date:5/23/2012)... Tactile, Inc. (MTI), with the support of The Pre-Mammogram ... developed a pre-commercial SureTouch™ Wireless system that ... According to a publication funded by ... were diagnosed with breast cancer in 2010 and 425,000 ... the best means to a good prognosis for breast ...
(Date:5/23/2012)... 2012   CryoLife, Inc. (NYSE: ... cardiac and vascular surgery, announced today that it will ... One-on-One Investor Conference on Thursday, May 31, 2012 in ... chief operating officer, and chief financial officer of CryoLife, ... conference will allow institutional investors to meet with the ...
(Date:5/23/2012)... 2012 QRxPharma Limited (ASX: QRX and OTCQX: ... Trademark Office (USPTO) issued the Company U.S. Patent No. ... covers a method of treatment of pain comprising the ... compositions of MoxDuo IR (Immediate Release) for the ... (Controlled Release) for the treatment of chronic pain. ...
Breaking Medicine Technology:Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 2Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 3Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 4CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference 2QRxPharma Granted Additional US Patent on MoxDuo® 2QRxPharma Granted Additional US Patent on MoxDuo® 3Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 1Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 1Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 3Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 4Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 5Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 6Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 7Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 1Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 2Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 3Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 4
... NovaDel Pharma,Inc. (AMEX: NVD), a specialty pharmaceutical ... range of marketed treatments,today announced that its ... zolpidem tablets have met their primary,pharmacokinetic (PK), ... currently marketed as Ambien(R), a leading,drug for ...
... Oral Presentation Reports Significantly More Patients ... Least Three,Years, CHICAGO, June 04, 2007 ... (Taxotere plus,prednisone) maintained long-term efficacy as ... cancer patients,according to the three-year updated ...
Other Medicine Technology:NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: